242 related articles for article (PubMed ID: 34758846)
21. The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta-analysis.
Hu J; Xu Z; Ye Z; Li J; Hao Z; Wang Y
Cancer Med; 2023 Jan; 12(1):541-556. PubMed ID: 35637613
[TBL] [Abstract][Full Text] [Related]
22. Coffee and caffeine intake and risk of ovarian cancer: a systematic review and meta-analysis.
Shafiei F; Salari-Moghaddam A; Milajerdi A; Larijani B; Esmaillzadeh A
Int J Gynecol Cancer; 2019 Mar; 29(3):579-584. PubMed ID: 30833443
[TBL] [Abstract][Full Text] [Related]
23. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
24. Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk.
Zhang L; Liu W; Hao Q; Bao L; Wang K
Int J Mol Sci; 2012; 13(4):4009-4020. PubMed ID: 22605962
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of methalenetetrahydrofolate reductase in recurrent pregnancy loss: an overview of systematic reviews and meta-analyses.
Du B; Shi X; Yin C; Feng X
J Assist Reprod Genet; 2019 Jul; 36(7):1315-1328. PubMed ID: 31254142
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.
Campbell JM; Bateman E; Stephenson MD; Bowen JM; Keefe DM; Peters MD
Cancer Chemother Pharmacol; 2016 Jul; 78(1):27-39. PubMed ID: 27142726
[TBL] [Abstract][Full Text] [Related]
27. Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies.
Giannakou K; Evangelou E; Papatheodorou SI
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):720-730. PubMed ID: 29143991
[TBL] [Abstract][Full Text] [Related]
28. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies.
Liang H; Yan Y; Li T; Li R; Li M; Li S; Qin X
Tumour Biol; 2014 Feb; 35(2):1695-701. PubMed ID: 24078451
[TBL] [Abstract][Full Text] [Related]
29. Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis.
Wei H; Zhu Y; Wang T; Zhang X; Zhang K; Zhang Z
J Neural Transm (Vienna); 2021 Jun; 128(6):717-734. PubMed ID: 34115189
[TBL] [Abstract][Full Text] [Related]
30. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
[TBL] [Abstract][Full Text] [Related]
31. Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.
Fu LY; Dai LM; Li XG; Zhang K; Bai Y
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():56-61. PubMed ID: 24192663
[TBL] [Abstract][Full Text] [Related]
32. Effect of polymorphisms of MTHFR in controlled ovarian stimulation: a systematic review and meta-analysis.
Wang X; Sun X; Tang B; Liu L; Feng X
J Assist Reprod Genet; 2021 Sep; 38(9):2237-2249. PubMed ID: 34032987
[TBL] [Abstract][Full Text] [Related]
33. The Association Between MTHFR C677T Gene Polymorphism and Repeated Pregnancy Loss in Arabic Countries: a Systematic Review and Meta-Analysis.
Alfaleh A; Alkattan A; Mahmoud N; Alfaleh F; Almutair N; Alanazi A; Kbbash I; Radwan N
Reprod Sci; 2023 Jul; 30(7):2060-2068. PubMed ID: 36854824
[TBL] [Abstract][Full Text] [Related]
34. MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.
Wu CY; Yang M; Lin M; Li LP; Wen XZ
Arch Gynecol Obstet; 2013 Sep; 288(3):595-605. PubMed ID: 23463325
[TBL] [Abstract][Full Text] [Related]
35. MTHFR polymorphisms in relation to ovarian cancer risk.
Terry KL; Tworoger SS; Goode EL; Gates MA; Titus-Ernstoff L; Kelemen LE; Sellers TA; Hankinson SE; Cramer DW
Gynecol Oncol; 2010 Nov; 119(2):319-24. PubMed ID: 20817226
[TBL] [Abstract][Full Text] [Related]
36. Association of smoking, alcohol, and coffee consumption with the risk of ovarian cancer and prognosis: a mendelian randomization study.
Liu S; Feng S; Du F; Zhang K; Shen Y
BMC Cancer; 2023 Mar; 23(1):256. PubMed ID: 36941558
[TBL] [Abstract][Full Text] [Related]
37. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.
Xia LZ; Liu Y; Xu XZ; Jiang PC; Ma G; Bu XF; Zhang YJ; Yu F; Xu KS; Li H
World J Gastroenterol; 2014 Aug; 20(32):11429-38. PubMed ID: 25170232
[TBL] [Abstract][Full Text] [Related]
38. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.
Zhu J; Wu L; Kohlmeier M; Ye F; Cai W
Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
